Moreover, survival of patients with breast and ovarian cancers was reduced with increased expression level of EphB4 but not of EpoR, and Epo treatment further reduced the survival chances of breast cancer patients with tumors that express high levels of EphB4 [185]. The gene discussed is EPHB4; the disease is breast cancer.